Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, agreed to acquire Mpirik, a healthcare intelligence platform that identifies critical findings, filters extraneous data, and facilitates communication. Financial terms were not disclosed. “The acquisition of Mpirik further solidifies our position as a leader in AI-enabled precision medicine, and doubles down on our commitment to helping cardiologists fight the number one killer worldwide – heart disease. This represents an important step forward to help the estimated hundreds of thousands of U.S. residents who die unnecessarily each year from heart disease and stroke as a result of underdiagnosis or undertreatment,” Eric Lefkofsky, Tempus Founder and CEO.